Kolexia
Schlumberger Martin Médecine nucléaire
Schlumberger Martin
Médecine nucléaire
Gustave-Roussy
Villejuif, France
380 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la thyroïde Carcinomes Carcinome papillaire Métastase tumorale Maladies de la thyroïde Carcinome anaplasique de la thyroïde Cancer papillaire de la thyroïde Carcinome neuroendocrine Adénocarcinome folliculaire

Collaborateurs

Voir plus
Leboulleux Sophie
Leboulleux Sophie
Gustave-Roussy, Villejuif, France
Baudin Eric
Baudin Eric
Gustave-Roussy, Villejuif, France
Deandreis Desiree
Deandreis Desiree
Gustave-Roussy, Villejuif, France
Al Ghuzlan Abir
Al Ghuzlan Abir
Gustave-Roussy, Villejuif, France

Industries

Voir plus
Bayer
6 collaboration(s)
Dernière en 2018
Eisai
2 collaboration(s)
Dernière en 2018
Ipsen
1 collaboration(s)
Dernière en 2018
Sanofi
1 collaboration(s)
Dernière en 2019

Dernières activités

Voir plus
Estimabl2 trial: Thyroidectomy without radioiodine in patients with low-risk thyroid cancer, 5 years of follow-up
39e congrès de la Société Française d'Endocrinologie 2023   01 octobre 2023
Skeletal related events in differentiated thyroid cancer with bone metastasis: A bicentric study
39e congrès de la Société Française d'Endocrinologie 2023   01 octobre 2023
An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer: An International, Phase III, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study to Assess the Efficacy of ZD6474 (ZACTIMATM) Versus Placebo in Subjects With Unresectable Locally Advanced or Metastatic Medullary Thyroid Cancer
Essai Clinique (Sanofi)   22 septembre 2023
D898_E901 Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms.
JCO precision oncology   07 août 2023
MERAIODE: A Phase II Redifferentiation Trial with Trametinib and I in Metastatic Radioactive Iodine Refractory Mutated Differentiated Thyroid Cancer.
Thyroid : official journal of the American Thyroid Association   26 juillet 2023
Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial.
Trials   11 juillet 2023
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research   06 juillet 2023
SELECT: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer
Essai Clinique (Eisai)   16 juin 2023
RIFTOS MKI - Radioactive Iodine reFractory Asymptomatic Patients in Differentiated Thyroid Cancer - an Observational Study to Assess the Use of Multikinase Inhibitors
Essai Clinique (Bayer)   07 juin 2023
Increasing the efficiency of a mobile EPI strategy using injectable polio vaccine in Africa.
Medecine tropicale et sante internationale   02 juin 2023